Latest Refinancing News

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

QuickFee Limited has reported a robust 77% increase in Australian originations for Q4 FY26 to-date, driven by strong Fee Funding and Disbursement Funding growth. The company boosted its Australian credit facility by A$15 million, signalling confidence in its low-risk lending model, while US operations focus on reseller channel expansion amid a product embedding delay.

Greatland Resources has locked in a $500 million debt facility with major banks, boosting liquidity to over $1.7 billion as it commits to developing its Havieron gold-copper project.

Elanor Investors Group has called off its planned acquisition of Singapore-based Firmus Capital due to prolonged regulatory delays, while reaffirming its $125 million recapitalisation with Rockworth Capital Partners and seeking ASX trading reinstatement.

Champion Iron Limited reported a 19% increase in net profit to C$168.7 million for FY2026, driven by record production and sales, progress on its DRPF project, and the strategic acquisition of Rana Gruber.

Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.

Blackpearl Group has posted a record 114% jump in Annual Recurring Revenue to NZD 26.8 million, powered by its Pearl Engine vertical AI model that benchmarks 25 times better than leading generalist AI. Despite deepening losses, the firm targets balanced growth and cash conversion in FY27.

Stride Property Group posted a 44% jump in FY26 profit after tax to $31.3 million, driven by strategic portfolio moves, management fee growth, and sustainability progress. The group maintained an 8.0cps dividend amid a $1.4 billion diversified property portfolio and a strong balance sheet.

Australian Vintage Limited has locked in a $128 million refinancing deal extending to 2029 and reported a significant cash flow turnaround in FY26, driven by innovation and strategic acquisitions.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

Schoolblazer Limited delivers its inaugural consolidated results following a strategic pivot to global schoolwear, posting $55.3 million revenue but a $15.2 million statutory loss amid integration and supply chain challenges.

Nexalis Therapeutics (ASX: NX1) has voluntarily suspended trading of its shares pending a material announcement on its existing debt funding facility, extending a recent trading halt. The suspension is set to last until the earlier of the announcement release or resumption of trading on 28 May 2026.